EUVIMEDEUVIMED entdecken
Übersichtsarbeit

One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract

Stephanie A Berg, Bradley A McGregor

Current Treatment Options in Oncology · 2024

DOI: 10.1007/s11864-024-01187-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Treatment Options in Oncology, 2024. Verfasst von Stephanie A Berg und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dana-Farber Cancer Institute, Lank Center for Genitourinary Oncology, 44 Binney Street, Boston, MA, 02115, USA. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Urinary Tract. Die Arbeit nennt 71 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OPINION STATEMENT: Urothelial carcinoma is the predominant cancer of the urinary tract but when divergent and subtype histology (non-urothelial) are identified at time of pathologic diagnosis, therapeutic and diagnostic challenges transpire. To this end, pathologic review to confirm any non-urothelial histology is key since these subtypes can often be overlooked. Few prospective trials are dedicated to understanding these non-urothelial histologic types; however, current, and past trials did allow patients with these non-urothelial histologic types to enroll, and inferences can be made about treatment efficacy and survival. Existing treatment regimens for non-urothelial bladder cancers are akin to standard urothelial cancer regimens using surgical approaches for localized disease and platinum-based chemotherapy for advanced disease. The reported clinical trials, that will be discussed, center on non-urothelial histologic types. These studies, albeit limited, provide critical insight into tumor biology and response to standard platinum-based chemotherapy, immune checkpoint inhibitors, and antibody drug conjugates. The inclusion of non-urothelial histologic types will be essential for clinical trials in development to provide further therapeutic advances and provide essential efficacy data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCarcinoma, Transitional CellUrinary TractHumansProspective StudiesTreatment Outcome

Stichwörter der Autor:innen

Divergent and subtype histologyGenitourinary tumorsUrothelial carcinoma

Autor:innen und Institutionen

  • Dana-Farber Cancer Institute, Lank Center for Genitourinary Oncology, 44 Binney Street, Boston, MA, 02115, USA.
  • Dana-Farber Cancer Institute, Lank Center for Genitourinary Oncology, 44 Binney Street, Boston, MA, 02115, USA. bradley_mcgregor@dfci.harvard.edu.

Zitieren

APA

Berg, S. A., & McGregor, B. A. (2024). One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract. Current Treatment Options in Oncology. https://doi.org/10.1007/s11864-024-01187-3

Vancouver

Berg SA, McGregor BA. One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract. Current Treatment Options in Oncology. 2024. doi:10.1007/s11864-024-01187-3

BibTeX
@article{Berg2024,
  author = {Berg, Stephanie A and McGregor, Bradley A},
  title = {One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract},
  journal = {Current Treatment Options in Oncology},
  year = {2024},
  doi = {10.1007/s11864-024-01187-3}
}
Kostenlos starten →